Science and Technology
Quincy Bioscience is pursuing novel therapeutics for the treatment of the diseases of aging. The company's technology has led to patent filings for applications of the calcium-binding protein apoaequorin. Apoaequorin comes from the jellyfish - an organism with one of the simplest nervous systems. While apoaequorin has been commonly used in laboratory research for over forty-five years, to date, it had never been used in any therapeutic manner before Quincy Bioscience's research began. Apoaequorin is unique in that it is from a family of molecules that are called calcium-binding proteins. Calcium-binding proteins are known to deplete in the aging process. Quincy Bioscience sets itself apart through its introduction of apoaequorin to help the restoration of calcium homeostasis in the human body.
